RadNet, Inc. (RDNT)
RadNet, Inc. (RDNT) from its SEC filings: 2025 revenue $2.0 billion (+12% vs the year before), net margin -1%, free cash flow $298.8 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Services-Medical Laboratories |
| Revenue (2025) | $2.0 billion |
| Revenue growth | +12% |
| Net income | -$18.6 million |
| Net margin | -0.9% |
| Free cash flow | $298.8 million |
| Diluted EPS | $-0.25 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +25% |
| Cash | $726.3 million |
| Long-term debt | $1.3 billion |
| Share count, 1 year | +2% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.